With increased COVID-19 testing and confirmed cases growing, Americans with High-Deductible Health Plans (HDHPs) are worried they’ll face high out-of-pocket costs from deductibles, copays, or coinsurance as a result of the virus..
IRS Notice 2020-15 has clarified this, as it relates to HDHPs.
The notice sets out to “[remove] barriers to testing for and treatment of COVID-19” and “[provide] flexibility to HDHPs to provide health benefits for testing and treatment of COVID-19 without application of a deductible or cost-sharing.”
Under the revised IRS provision, HDHPs otherwise qualified as HSA-eligible plans will not lose their status as HSA-eligible by adding coverage of testing and treatment of COVID-19.
You can read more detail here.
(Effective as of March 11, 2020)